Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127435531 | 12743553 | 1 | I | 20080313 | 20160907 | 20160914 | 20160914 | PER | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-58702BP | BOEHRINGER INGELHEIM | 77.00 | YR | F | Y | 67.60000 | KG | 20160914 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127435531 | 12743553 | 1 | PS | ATROVENT | IPRATROPIUM BROMIDE | 1 | Respiratory (inhalation) | DOSE PER APPLICATION: 0.02% IN 2.5ML | Y | 21527 | Q6H | ||||||||
| 127435531 | 12743553 | 2 | SS | AMINOPHYLLINE. | AMINOPHYLLINE | 1 | Intravenous (not otherwise specified) | Y | 0 | 16 | MG | ||||||||
| 127435531 | 12743553 | 3 | SS | ALBUTEROL. | ALBUTEROL | 1 | Respiratory (inhalation) | DOSE PER APPLICATION: 2.5MG IN 0.5ML | Y | 0 | Q2H | ||||||||
| 127435531 | 12743553 | 4 | C | CELECOXIB. | CELECOXIB | 1 | Oral | 3 ANZ | 0 | TABLET | TID | ||||||||
| 127435531 | 12743553 | 5 | C | CELECOXIB. | CELECOXIB | 1 | 0 | ||||||||||||
| 127435531 | 12743553 | 6 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 0 | |||||||||||
| 127435531 | 12743553 | 7 | C | AVAPRO | IRBESARTAN | 1 | Oral | 0 | |||||||||||
| 127435531 | 12743553 | 8 | C | ASA | ASPIRIN | 1 | Oral | 0 | TABLET | ||||||||||
| 127435531 | 12743553 | 9 | C | ATIVAN | LORAZEPAM | 1 | Oral | 0 | TABLET | ||||||||||
| 127435531 | 12743553 | 10 | C | COMBIVENT | ALBUTEROL SULFATEIPRATROPIUM BROMIDE | 1 | Oral | 0 | |||||||||||
| 127435531 | 12743553 | 11 | C | TYLENOL EXTRA STRENGTH | ACETAMINOPHEN | 1 | Unknown | 0 | |||||||||||
| 127435531 | 12743553 | 12 | C | TYLENOL EXTRA STRENGTH | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 127435531 | 12743553 | 13 | C | LEVAQUIN | LEVOFLOXACIN | 1 | Oral | 0 | TABLET | ||||||||||
| 127435531 | 12743553 | 14 | C | CARDIZEM CD | DILTIAZEM HYDROCHLORIDE | 1 | Oral | 0 | TABLET | ||||||||||
| 127435531 | 12743553 | 15 | C | FLUTICASONE PROPIONATE. | FLUTICASONE PROPIONATE | 1 | Unknown | 0 | |||||||||||
| 127435531 | 12743553 | 16 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | DOSE PER APPLICATION: 500/50 UNKNOWN UNIT | 0 | BID | |||||||||
| 127435531 | 12743553 | 17 | C | SPIRIVA | TIOTROPIUM BROMIDE MONOHYDRATE | 1 | Respiratory (inhalation) | 18 MCG | 0 | 18 | UG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127435531 | 12743553 | 1 | Chronic obstructive pulmonary disease |
| 127435531 | 12743553 | 2 | Product used for unknown indication |
| 127435531 | 12743553 | 3 | Product used for unknown indication |
| 127435531 | 12743553 | 4 | Osteoarthritis |
| 127435531 | 12743553 | 5 | Rheumatoid arthritis |
| 127435531 | 12743553 | 6 | Product used for unknown indication |
| 127435531 | 12743553 | 7 | Product used for unknown indication |
| 127435531 | 12743553 | 8 | Hypertension |
| 127435531 | 12743553 | 9 | Anxiety |
| 127435531 | 12743553 | 10 | Chronic obstructive pulmonary disease |
| 127435531 | 12743553 | 11 | Back pain |
| 127435531 | 12743553 | 12 | Headache |
| 127435531 | 12743553 | 13 | Chronic obstructive pulmonary disease |
| 127435531 | 12743553 | 14 | Hypertension |
| 127435531 | 12743553 | 15 | Product used for unknown indication |
| 127435531 | 12743553 | 16 | Product used for unknown indication |
| 127435531 | 12743553 | 17 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127435531 | 12743553 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127435531 | 12743553 | Atrial fibrillation | |
| 127435531 | 12743553 | Chronic obstructive pulmonary disease |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127435531 | 12743553 | 1 | 20080313 | 20080316 | 0 | |
| 127435531 | 12743553 | 2 | 20080313 | 20080316 | 0 | |
| 127435531 | 12743553 | 3 | 20080313 | 20080316 | 0 | |
| 127435531 | 12743553 | 4 | 20071121 | 20080101 | 0 | |
| 127435531 | 12743553 | 6 | 20050105 | 0 | ||
| 127435531 | 12743553 | 7 | 20071220 | 0 | ||
| 127435531 | 12743553 | 8 | 20080313 | 0 | ||
| 127435531 | 12743553 | 9 | 20080313 | 0 | ||
| 127435531 | 12743553 | 10 | 20080313 | 0 | ||
| 127435531 | 12743553 | 11 | 20080201 | 0 | ||
| 127435531 | 12743553 | 13 | 20080313 | 20080323 | 0 | |
| 127435531 | 12743553 | 14 | 20080313 | 20080323 | 0 | |
| 127435531 | 12743553 | 16 | 20051209 | 0 | ||
| 127435531 | 12743553 | 17 | 20050510 | 0 |